Dyne Therapeutics, Inc. ($DYN)
Friedl-Naderer Johanna โ Chief Commercial Officer
Shares
228
Price
$18.36
Total Value
$4,186.08
Nearby Earnings
May 6, 2026
Transaction Details
| Insider | Friedl-Naderer Johanna |
|---|---|
| Title | Chief Commercial Officer |
| Transaction Date | May 13, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | May 14, 2026 |
| Shares Sold | 228 |
| Price per Share | $18.36 |
| Total Value | $4,186.08 |
| Shares Owned After | 154,353 |
| Derivative | No |
| Accession Number | 0001193125-26-223984 |
| Document | View SEC Filing |